Sequana Medical NV (XBRU:SEQUA) Additional Paid-In Capital : €185.64 Mil(As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV Additional Paid-In Capital?

Sequana Medical NV's quarterly additional paid-in capital stayed the same from Jun. 2022 (€170.32 Mil) to Dec. 2022 (€170.32 Mil) but then increased from Dec. 2022 (€170.32 Mil) to Jun. 2023 (€185.64 Mil).

Sequana Medical NV's annual additional paid-in capital increased from Dec. 2020 (€119.33 Mil) to Dec. 2021 (€142.43 Mil) and increased from Dec. 2021 (€142.43 Mil) to Dec. 2022 (€170.32 Mil).

Sequana Medical NV Additional Paid-In Capital Historical Data

The historical data trend for Sequana Medical NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Additional Paid-In Capital Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

64.96

100.66

119.33

142.43

170.32

Sequana Medical NV Semi-Annual Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial									142.43	142.43	170.32	170.32	185.64

Sequana Medical NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sequana Medical NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (XBRU:SEQUA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (XBRU:SEQUA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

2SE:Germany

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (XBRU:SEQUA) Headlines

No Headlines